The Centre for Drug Research and Development (CDRD), a public funded pharmaceutical agency based in Vancouver, has signed a research deal with healthcare company F. Hoffmann-La Roche Ltd, it was announced on 26 September.
Under the agreement, Roche will provide an undisclosed amount of funding, thought to be millions of Canadian dollars, to CDRD’s commercial arm, CDRD Ventures Inc. (CVI), for the joint development of medical technologies.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.